BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 11084537)

  • 1. Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
    Hoyer J; Vasileiou G; Uebe S; Wunderle M; Kraus C; Fasching PA; Thiel CT; Hartmann A; Beckmann MW; Lux MP; Reis A
    BMC Cancer; 2018 Sep; 18(1):926. PubMed ID: 30257646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation.
    El Tannouri R; Albuisson E; Jonveaux P; Luporsi E
    Fam Cancer; 2019 Jan; 18(1):1-8. PubMed ID: 29550896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?
    El Tannouri R; Albuisson E; Jonveaux P; Luporsi E
    Fam Cancer; 2018 Jan; 17(1):5-14. PubMed ID: 28493033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.
    Muller D; Bonaiti-Pellié C; Abecassis J; Stoppa-Lyonnet D; Fricker JP
    Fam Cancer; 2004; 3(1):15-20. PubMed ID: 15131401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer.
    Rostagno P; Gioanni J; Garino E; Vallino P; Namer M; Frenay M
    J Hum Genet; 2003; 48(7):362-6. PubMed ID: 12827452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes implicated in hereditary breast cancer syndromes.
    Tonin PN
    Semin Surg Oncol; 2000 Jun; 18(4):281-6. PubMed ID: 10805949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Germ-line mutations of the BRCA1 gene in northeastern France].
    Fricker JP; Muller D; Cutuli B; Rodier JF; Janser JC; Jung GM; Mors R; Petit T; Haegele P; Abecassis J
    Bull Cancer; 2000 Oct; 87(10):739-44. PubMed ID: 11084537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial breast cancer].
    Fukutomi T; Inoue R; Ushijima T; Toyoda M
    Nihon Rinsho; 1995 Nov; 53(11):2764-8. PubMed ID: 8538041
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.